Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1789407

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1789407

Artificial Organ Market, By Organ Type, By Patient Type, By End User, By Application, By Technology, By Geography

PUBLISHED:
PAGES: 168 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Artificial Organ Market is estimated to be valued at USD 21.51 Bn in 2025 and is expected to reach USD 38.32 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 21.51 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.60% 2032 Value Projection: USD 38.32 Bn

The global artificial organ market represents a revolutionary frontier in medical technology, addressing the critical shortage of donor organs worldwide while offering hope to millions of patients suffering from organ failure. Artificial organs, engineered medical devices designed to replace or support the function of failing biological organs, encompass a diverse range of technologies including mechanical devices, bioengineered tissues, and hybrid systems.

This market spans various organ types such as artificial hearts, kidneys, lungs, liver, pancreas, and limbs, each utilizing sophisticated materials science, biocompatibility engineering, and advanced manufacturing techniques. The increasing prevalence of chronic diseases, aging populations, and lifestyle-related organ failures has intensified the demand for artificial organ solutions. These life-saving technologies range from temporary bridging devices that sustain patients awaiting transplants to permanent organ replacements that restore normal physiological function.

The market encompasses both implantable devices and external support systems, leveraging cutting-edge innovations in biomaterials, 3D printing, tissue engineering, and regenerative medicine. As healthcare systems worldwide grapple with organ donor shortages and extended waiting lists, artificial organs emerge as a promising alternative, offering immediate availability, customizable specifications, and elimination of immunological rejection risks associated with traditional organ transplantation.

Market Dynamics

The global artificial organ market is propelled by several compelling drivers that underscore its critical importance in modern healthcare. The primary driver stems from the severe shortage of donor organs worldwide, with over 100,000 Americans currently on organ waiting lists and similar statistics globally, creating an urgent need for artificial alternatives. Rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, kidney failure, and liver cirrhosis, coupled with aging populations, significantly amplifies demand for organ replacement solutions.

Technological advancements in biomaterials, 3D bioprinting, tissue engineering, and nanotechnology are revolutionizing artificial organ development, making devices more biocompatible, durable, and functionally superior. Government initiatives supporting research and development, increased healthcare expenditure, and growing awareness about artificial organ benefits further accelerate market growth. However, the market faces substantial restraints including extremely high development and manufacturing costs, making artificial organs expensive and potentially inaccessible to many patients. Stringent regulatory approval processes requiring extensive clinical trials and safety validations create lengthy timelines and significant financial barriers for manufacturers. Technical challenges related to biocompatibility, device longevity, infection risks, and achieving natural organ functionality remain significant hurdles. Limited reimbursement coverage by insurance providers and ethical concerns regarding artificial organ implementation also constrain market expansion.

Despite these challenges, immense opportunities exist through emerging markets with improving healthcare infrastructure, increasing medical tourism, and rising disposable incomes. Collaborative research between academic institutions, biotechnology companies, and medical device manufacturers is fostering innovation and accelerating product development. The integration of artificial intelligence, machine learning, and IoT technologies in artificial organ design presents revolutionary opportunities for smart, adaptive devices that can monitor and adjust their functionality in real-time, potentially transforming patient outcomes and market dynamics.

Key features of the study

  • This report provides an in-depth analysis of the global artificial organ market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global artificial organ market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include leading Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Asahi Kasei Corporation, Fresenius Medical Care AG, Baxter International Inc., SynCardia Systems LLC, Jarvik Heart Inc., Cochlear Limited, Ottobock SE & Co. KGaA, Second Sight Medical Products, Ekso Bionics Holdings Inc., Abiomed Inc., Organovo Holdings Inc., and Carmat SA.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global artificial organ market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial organ market.

Market Segmentation

  • Organ Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Artificial Heart
    • Ventricular Assist Devices (VADs)
    • Total Artificial Hearts (TAHs)
    • Artificial Kidney
    • Wearable Artificial Kidneys
    • Implantable Renal Devices
    • Artificial Liver
    • Bioartificial Liver Support Systems
    • Extracorporeal Liver Assist Devices
    • Artificial Pancreas
    • Closed-Loop Insulin Delivery Systems
    • Implantable Glucose Monitors
    • Artificial Lungs
    • Extracorporeal Membrane Oxygenation (ECMO)
    • Implantable Oxygenators
    • Sensory Organs
    • Cochlear Implants (Hearing)
    • Retinal Implants (Vision)
    • Corneal Implants
    • Bionic Limbs
    • Myoelectric Prosthetics
    • Others (Neuro-Controlled Prostheses)
  • Patient Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Neonates
    • Pediatric
    • Adult
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Transplant Centers
    • Ambulatory Surgical Centers
    • Emergency and Trauma Centers
    • Home Care Settings
    • Others (Research Institutes, etc.)
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Transplantation
    • Chronic Disease Management
    • Other Emergency or Acute Care
  • Technology Insights (Revenue, USD Bn, 2020 - 2032)
    • Mechanical
    • Electronic or Bionic
    • Biomechanical Hybrid
    • Biomaterials-Based Technology (e.g., Decellularized Scaffolds, 3D-Bioprinted Tissues)
    • Others
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Abbott Laboratories
    • Medtronic plc
    • Boston Scientific Corporation
    • Asahi Kasei Corporation
    • Fresenius Medical Care AG
    • Baxter International Inc.
    • SynCardia Systems LLC
    • Jarvik Heart Inc.
    • Cochlear Limited
    • Ottobock SE & Co. KGaA
    • Second Sight Medical Products
    • Ekso Bionics Holdings Inc.
    • Abiomed Inc.
    • Organovo Holdings Inc.
    • Carmat SA
Product Code: CMI8264

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Artificial Organ Market, By Organ Type
    • Global Artificial Organ Market, By Patient Type
    • Global Artificial Organ Market, By End User
    • Global Artificial Organ Market, By Application
    • Global Artificial Organ Market, By Technology
    • Global Artificial Organ Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Artificial Organ Market, By Organ Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Artificial Heart
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Ventricular Assist Devices (VADs)
      • Total Artificial Hearts (TAHs)
  • Artificial Kidney
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Wearable Artificial Kidneys
      • Implantable Renal Devices
  • Artificial Liver
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Bioartificial Liver Support Systems
      • Extracorporeal Liver Assist Devices
  • Artificial Pancreas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Closed-Loop Insulin Delivery Systems
      • Implantable Glucose Monitors
  • Artificial Lungs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Extracorporeal Membrane Oxygenation (ECMO)
      • Implantable Oxygenators
  • Sensory Organs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Cochlear Implants (Hearing)
      • Retinal Implants (Vision)
  • Corneal Implants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Bionic Limbs
      • Myoelectric Prosthetics
  • Others (Neuro-Controlled Prostheses)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Artificial Organ Market, By Patient Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Neonates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Artificial Organ Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Transplant Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Emergency and Trauma Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Research Institutes, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Artificial Organ Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Transplantation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Chronic Disease Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Emergency or Acute Care
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Artificial Organ Market, By Technology, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Mechanical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Electronic or Bionic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biomechanical Hybrid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biomaterials-Based Technology (e.g., Decellularized Scaffolds, 3D-Bioprinted Tissues)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Artificial Organ Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Organ Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Organ Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Organ Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Organ Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Organ Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Organ Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Asahi Kasei Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fresenius Medical Care AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Baxter International Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • SynCardia Systems LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Jarvik Heart Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cochlear Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ottobock SE & Co. KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Second Sight Medical Products
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ekso Bionics Holdings Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abiomed Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Organovo Holdings Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Carmat SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!